Register Login

PTC Therapeutics Inc (PTCT)

SCHMERTZLER MICHAEL 🟢 acquired 14.9K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $76.74 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 11:43 p.m.

    🔍 SCHMERTZLER MICHAEL (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 14,950

    Detailed Transactions and Holdings:

    • Acquired 8,000 shares of Common Stock (Direct)
      Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 163,266.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 6,950 shares of Stock Option (Right to Buy) at $76.74 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 6,950.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.
    • F2: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Search

News categories